Cytek Biosciences Inc expected to post earnings of 3  cents a share - Earnings Preview

Cytek Biosciences

06/05/2023 03:03

* Cytek Biosciences Inc  CTKB.OQ   CTKB.O  is expected
to show a
rise in quarterly revenue when it reports  results on May 9. 
    * The Fremont California-based  company is expected to
report  a
34.5% increase in revenue to $47.146 million from $35.06 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Cytek Biosciences
Inc is
for earnings of 3 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cytek
Biosciences
Inc is $14.5​, above​ its last closing price of $11.92. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  0.05        0.05       0.06      Beat    28.6
 Sep. 30 2022  0.02        0.02       0.04      Beat    100
 Jun. 30 2022  0.03        0.02       0.03      Beat    80​
 Mar. 31 2022  -0.01       0.00       0.01      Beat    300
 ​​Dec.        0.02        0.03       0.03      Met     20
 31 2021                                                
 Sep. 30 2021  0.03        0.02       0.02      Met     -14.3​
 Jun. 30 2021  0.02        0.02       0.00      Missed  -100
 This summary was machine generated May 6 at 02:03 GMT.  All
figures in US dollars  unless otherwise stated